#041 Prices of Expensive Diabetes Drugs Are Falling And More Manufacturers Are Rushing In
On today’s episode, financial journalist Govindraj Ethiraj talks to Sheetal Sapale, VP Commercial at Pharmarack SHOW NOTES [00:51] Taiwan’s Foxconn formally pulls out of Vedanta JV from a much touted $19.5 billion semiconductor manufacturing project.[06:37] How India’s diabetics drug market is exploding as off-patent…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Core Report
See all episodes →
#963 The ₹25 Crore Retirement Reality Every Indian Must Know | Saurabh Mukherjea | The Core Report
#962 Why ChatGPT Could Make Your Brand Invisible | Kirthiga Reddy | Govindraj Ethiraj | The Core Report
#961 Benchmarks Slide Again Despite Oil Prices Falling
Similar episodes from other shows
More like The Core Report →
Diabetes Drugs: Bittersweet Truth of Patent Expiries
The price drop in weight-loss drugs Indian pharma can’t handle
When price caps on pharma drugs fail
Can India become the pharmacy for weight-loss drugs?
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.